DarioHealth Corp.

DarioHealth Corp. is a billboard sponsor of Streetwise Reports and paid a fee for this company profile page. Please refer to the important disclosures below for additional details.

Recent Articles:

AI Chronic Care Platform Adds Fifth Fortune 50 Client, Lifts Margin to 62%

Streetwise Reports  (08/12/2026)

DarioHealth reported Q2 revenue of $5.2 million with gross margin rising to 62 percent and contracted ARR reaching $13.1 million after signing a fifth Fortune 50 client and expanding provider-backed care.

Tags: Life Sciences Tools & Diagnostics

DarioHealth Reports Q2 Revenue, with 62% Gross Margin as AI Platform Expands

Streetwise Reports  (08/12/2026)

DarioHealth Corp. (DRIO:NASDAQ) reported US$5.2 million in Q2 revenue, a 62% gross margin and US$13.1 million in contracted and late-stage ARR.

Tags: Life Sciences Tools & Diagnostics

Digital Health Provider Launches Women's Health and Sleep Solutions

Streetwise Reports  (08/06/2026)

DarioHealth expands its cardiometabolic platform with Dario Women and Dario Sleep programs. Revenue contribution expected late 2026 amid rising demand for multi-condition digital care solutions.

Tags: Healthcare Services

AI Health Platform Expands Into Women's Health and Sleep With New Revenue Expected in Q4

Streetwise Reports  (08/06/2026)

DarioHealth Corp. (DRIO:NASDAQ) launched Dario Women and Dario Sleep, expanding its provider-backed cardiometabolic platform with programs expected to begin contributing recurring revenue in the fourth quarter.

Tags: Healthcare Services

Digital Health Firm Launches Integrated GLP-1 Program

Streetwise Reports  (08/03/2026)

DarioHealth integrates its digital platform with licensed providers to offer end-to-end GLP-1 support. See how the new program targets employers and health plans in a growing market.

Tags: Biotechnology / PharmaceuticalsHealthcare Services

New GLP-1 Platform Combines Doctor Prescriptions, AI Coaching and Chronic Care

Streetwise Reports  (08/03/2026)

DarioHealth Corp. (NASDAQ: DRIO) introduced its Integrated GLP-1 Program, bringing licensed provider evaluations, FDA-approved GLP-1 prescribing where clinically appropriate and ongoing care into one experience.

Tags: Biotechnology / PharmaceuticalsHealthcare Services

More Articles

DarioHealth AI Platform Targets 10-15% Revenue Growth from Existing Clients

Streetwise Reports  (07/15/2026)

DarioHealth's DarioIQ AI engine is positioned to lift B2B2C recurring revenue 10-15% from current customers while the AI healthcare market expands rapidly toward hundreds of billions.

Tags: TechnologyHealthcare ServicesLife Sciences Tools & DiagnosticsArtificial Intelligence

AI Engine Delivers Engagement Gains as Recurring Revenue Outlook Climbs

Streetwise Reports  (07/15/2026)

DarioHealth Corp. (DRIO:NASDAQ) said its DarioIQ platform reflects the ongoing digital health rotation and AI transformation across healthcare, with broader deployment expected to increase recurring revenue from existing customers by 10% to 15%.

Tags: Life Sciences Tools & DiagnosticsHealthcare ServicesTechnologyArtificial Intelligence

DarioHealth (DRIO) Secures Arizona Insurer Deal via Amwell

Streetwise Reports  (07/08/2026)

DarioHealth (DRIO) gains access to hundreds of thousands of lives through a new Arizona health insurer agreement. Learn how its cardiometabolic platform and channel strategy create scalable employer opportunities.

Tags: Gold

Digital Health Platform Lands Access to Hundreds of Thousands of Covered Lives

Streetwise Reports  (07/08/2026)

DarioHealth Corp. (DRIO:NASDAQ) signed a new agreement through its Amwell partnership that makes its cardiometabolic platform available to a major Arizona health insurer's ASO business, representing hundreds of thousands of covered lives.

Tags: Healthcare Services

DarioHealth (DRIO) Expands Reach via Beluga Health Deal

Streetwise Reports  (07/01/2026)

DarioHealth (DRIO) integrates its AI platform with Beluga Health's network to scale provider-backed care. Discover growth catalysts, analyst targets, and investor considerations.

Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

Digital Health Pioneer Targets Massive Breakthrough Chronic Care Market

Streetwise Reports  (07/01/2026)

AI-driven digital health solutions pioneer DarioHealth Corp. (DRIO:NASDAQ) announces a partnership that it says will give it access to a network spanning all 50 states. Find out why analysts like the direction the company is taking.

Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

DarioHealth: Chronic Care Platform Drives Value

Streetwise Reports  (06/23/2026)

DarioHealth targets the booming digital health market with a multi-condition platform backed by 27 ADA studies. See pipeline growth, analyst targets, and key catalysts for investors.

Tags: Healthcare ServicesArtificial IntelligenceTechnologyMedical Devices

Four New ADA Studies Reveal Clinical Wins in Weight, Blood Sugar, and Healthcare Utilization

Streetwise Reports  (06/22/2026)

DarioHealth Corp. (DRIO:NASDAQ) presented four studies at the ADA Scientific Sessions reporting weight loss of up to 14.3%, fewer hospitalizations, and improved glycemic outcomes among high-risk cardiometabolic users of its digital health platform.

Tags: Healthcare ServicesArtificial IntelligenceTechnologyMedical Devices

New York Digital Health Firm Expands Reach to 116 Million Covered Lives

Streetwise Reports  (05/14/2026)

DarioHealth Corp. (DRIO:NASDAQ) reported first quarter 2026 results showing sequential revenue growth, lower operating expenses, expanded channel partnerships and a US$127 million commercial pipeline.

Tags: Healthcare Services

New York Healthcare Technology Co. Discovers Scalable Behavioral Health Breakthrough

Streetwise Reports  (04/28/2026)

DarioHealth Corp.'s (DRIO:NASDAQ) study showed measurable workplace productivity and cognitive function improvements in 1,254 users within weeks, boosting growth potential.

Tags: Life Sciences Tools & Diagnostics

DarioHealth Contracts With National Health Plan to Offer Behavioral Health Services to Millions of Members

Streetwise Reports  (10/14/2021)

DarioHealth Corp. shares traded 17% higher after the company reported it entered into an agreement with an unnamed national healthcare provider to make its behavioral health products available to millions of the plan's members.

Tags:  Healthcare ServicesTechnology

Experts Following This Company

Important Disclosures
DarioHealth Corp. is a Billboard advertiser of Streetwise Reports and pays a flat fee. Fees fund both sponsor-specific activities and general report activities. Sponsor-specific activities may include aggregating content and publishing that content on the Streetwise Reports site, creating and maintaining company landing pages, interviewing key management, posting a banner/billboard, and/or issuing press releases. The fees also cover the costs for Streetwise Reports to publish and syndicate investment opinion and comments, and also to curate or create sector-specific content. Billboard advertising monthly fees range from $3,000 to $5,000. This landing page contains a summary of the company that was prepared by that company. Some landing pages contain investing highlights and a catalyst calendar that are prepared by that company. The Expert Comments and Experts Following This Company sections of the landing page are compiled by Streetwise Reports. There may be other information about the company that is not placed on the landing page, and Streetwise Reports does not guarantee the accuracy or thoroughness of the information contained on the landing page. Readers should conduct their own research for all information publicly available concerning the company. This landing page may be considered advertising for the purposes of 18 U.S.C. 1734.